美因基因有限公司（「公司」或「美因基因」，股份代号：06667）于2026年1月5日发布截至2025年12月31日的股份变动月报表。
公告显示，公司本月底法定/注册股本维持在500,000,000股，面值每股USD 0.0001，对应注册股本总额USD 50,000，与上月相同。
截至报告期末，公司已发行普通股数量为224,300,200股，较上月底无任何增发、购回、注销或库藏变化。公司月内亦无股份期权、可换股票据等其他权利或激励计划的变动记录。
公司声明其股本管理符合香港联交所《上市规则》及相关法律法规。本次月报由董事姜晶签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.